Movano Inc(MOVE)
USD --+0.00%
Reward47Moderate
Risk53Moderate
📊75%Data
Revenue growing 60% YoY
MOVE
+0.0 · +0.00%
USD · NASDAQ
Movano Inc | Healthcare
Capital Destroyer
Market Cap:13.87M
ℹ️
Reward Rating
47
Moderate
Bottom 25% (model universe)
75% data coverage
ℹ️
Risk Rating
53
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on MOVE to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $300.00.

What is Movano Inc?

, a technology company, engages in the development of a platform to deliver healthcare solutions at the intersection of medical and consumer devices.

MOVE · Verdict

Moderate reward · elevated risk

MOVE's standout is balance sheet; cash flow and profitability weigh on the picture.

Based on 88% data coverage

MOVE · Verdict

What’s working & what to watch

Strengths 1

  • Balance sheet86/100

    Current ratio 3.02

Watchouts 2

  • Cash flow7/100

    -2225% free-cash-flow margin

  • Profitability9/100

    -2342% net margin · -399% ROE

Model-based scoring. For information only — not financial advice.

What is Movano Inc?

, a technology company, engages in the development of a platform to deliver healthcare solutions at the intersection of medical and consumer devices. It offers Evie Ring, a wearable device for women that combines health and wellness metrics comprising resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 13.87M.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (47)

The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap13.87M
P/E RatioN/A
Dividend YieldN/A
52 Week High49.762
52 Week Low4.67
Last AnnualDecember
IPO Date8/5/1999
IncorporatedUSA
Shares Outstanding1M
No. of Employees32
IndustryMedical Devices
ExchangeNASDAQ
Beta0.82
CurrencyUSD
Websitemovano.com